东兴证券两名保代遭监管约谈，曾参与泽达易盛IPO

Core Viewpoint - The regulatory scrutiny on investment banks and their representatives has intensified, particularly following the financial fraud case involving Zeda Yisheng, leading to disciplinary actions against two senior underwriters. Group 1: Regulatory Actions - Two underwriters, Hu Xiaoli and Tao Chenliang, are facing regulatory interviews due to their lack of diligence in their roles as sponsors for Zeda Yisheng's IPO project [1][2] - Both underwriters are currently listed under Class C (penalty classification) by the China Securities Association and are affiliated with Dongxing Securities [1][2] - The Beijing Securities Regulatory Bureau has scheduled the interviews for June 17, 2023, but did not disclose specific details about the projects involved [2] Group 2: Background of Zeda Yisheng Case - Zeda Yisheng went public on the STAR Market in June 2020, but was later found to have committed financial fraud over six years, inflating revenues by over 560 million yuan [1][4] - The company was forced to delist in May 2022 after being investigated for information disclosure violations, leading to penalties for the company and its associated intermediaries [1][4] Group 3: Broader Industry Implications - The year has seen a trend of strict regulatory measures against underwriters involved in problematic IPOs, with several facing penalties for withdrawing IPO applications [6][8] - Notable cases include penalties against underwriters from Zhongjin Securities and Guoyuan Securities for failing to adequately verify internal controls and financial disclosures [6][7] - The regulatory environment has led to some underwriters being banned from signing off on IPO applications for extended periods, with some facing bans of up to 24 months [8]